APA (7th ed.) Citation

P, S., H, G., R, J., S, S., SMR, S. M., F, T. A., & R, A. (2025). The synergistic renoprotective effects of valproate sodium and metformin in a diabetic nephropathy mouse model: Attenuation of pro-inflammatory markers and enhancement of Sirt1 and Bcl-2 expression. Renal failure, 47(1), 2579211. https://doi.org/10.1080/0886022X.2025.2579211

Chicago Style (17th ed.) Citation

P, Saberi-Hasanabadi, Ghalhenoi H, Jahani R, Saberi S, Sayedi Moqadam SMR, Talebpour Amiri F, and Ataee R. "The Synergistic Renoprotective Effects of Valproate Sodium and Metformin in a Diabetic Nephropathy Mouse Model: Attenuation of Pro-inflammatory Markers and Enhancement of Sirt1 and Bcl-2 Expression." Renal Failure 47, no. 1 (2025): 2579211. https://doi.org/10.1080/0886022X.2025.2579211.

MLA (9th ed.) Citation

P, Saberi-Hasanabadi, et al. "The Synergistic Renoprotective Effects of Valproate Sodium and Metformin in a Diabetic Nephropathy Mouse Model: Attenuation of Pro-inflammatory Markers and Enhancement of Sirt1 and Bcl-2 Expression." Renal Failure, vol. 47, no. 1, 2025, p. 2579211, https://doi.org/10.1080/0886022X.2025.2579211.